Tag: Turning Point Therapeutics

April 8, 2019 Off

Turning Point Therapeutics Appoints Annette North as Executive Vice President and General Counsel

SAN DIEGO–(BUSINESS WIRE)–Turning Point Therapeutics, Inc., a clinical-stage precision oncology company developing novel drugs that address treatment resistance, announced today…

April 1, 2019 Off

Turning Point Therapeutics’ Kinase Inhibitors Show High Potency against Targeted Oncogene Drivers and Their Mutations

By BusinessWire

Company Presents Four Studies at American Association for Cancer Research (AACR) Annual Conference Preclinical Data for Lead Asset Repotrectinib Continue…